EBS Operating Income

Emergent Biosolutions Inc · Operating Income

EBS logo

EBS Operating Income

Latest reported-$54.40M
EBS TTM Operating Income (-$386.30M → -$54.40M)
High-resolution chart · PNG

EBS operating income history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Emergent Biosolutions Inc Operating Income — Trailing twelve months (TTM) (USD)
Period endingOperating Income (USD)
-54,400,000
71,200,000
109,300,000
116,400,000
104,100,000
-99,900,000
-108,700,000
-143,000,000
-449,600,000
-539,000,000
-726,400,000
-737,900,000
-541,100,000
-324,000,000
-170,000,000
162,700,000
173,300,000
263,600,000
352,600,000
333,300,000
429,300,000
540,800,000
433,800,000
253,400,000
262,800,000
129,800,000
114,200,000
47,700,000
-1,700,000
72,100,000
89,800,000
131,692,000
158,161,000
99,890,000
124,300,000
122,137,000
109,846,000
99,275,001
105,522,001
119,739,001
147,420,001
190,981,000
141,514,000
120,988,000
88,861,000
55,204,000
58,056,000
36,729,000
23,844,000
30,694,000
42,802,000
40,539,000
32,209,000
26,150,000
26,962,000
51,922,000
43,513,000
55,067,000
32,099,000
21,072,000
40,269,000
34,873,000
73,557,000
42,719,000
18,163,000
26,062,000
40,150,000
36,879,000
56,168,000
36,016,000
29,925,000
72,229,000
61,313,000
50,098,000
33,092,000
33,833,000
27,454,000
58,059,000
85,838,000
2,950,000
33,874,000
40,893,000
47,912,000
37,232,000
29,139,000
21,046,000
12,953,000
-2,478,000
-58,052,000
-371,826,000
-386,300,000
-386,300,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.